March 5 (Reuters) – Eli Lilly said on Thursday it had rolled out a platform to help employers connect with organizations offering low-cost benefits and comprehensive obesity-care programs, aiming to widen access to its blockbuster weight-loss drug, Zepbound.
(Reporting by Mariam Sunny in Bengaluru; Editing by Maju Samuel)
Comments